ADUS vs. GH, RDNT, BTSG, SHC, OPCH, WGS, HTFL, PRVA, VCYT, and SGRY
Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Heartflow (HTFL), Privia Health Group (PRVA), Veracyte (VCYT), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry.
Addus HomeCare vs. Its Competitors
Addus HomeCare (NASDAQ:ADUS) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.
Addus HomeCare presently has a consensus target price of $137.50, suggesting a potential upside of 16.22%. Guardant Health has a consensus target price of $65.86, suggesting a potential upside of 0.61%. Given Addus HomeCare's higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Guardant Health.
Addus HomeCare has a net margin of 6.51% compared to Guardant Health's net margin of -49.93%. Addus HomeCare's return on equity of 9.39% beat Guardant Health's return on equity.
Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.
Addus HomeCare has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500.
95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 4.5% of Addus HomeCare shares are held by company insiders. Comparatively, 6.1% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Guardant Health had 5 more articles in the media than Addus HomeCare. MarketBeat recorded 7 mentions for Guardant Health and 2 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.67 beat Guardant Health's score of 0.65 indicating that Addus HomeCare is being referred to more favorably in the media.
Summary
Addus HomeCare beats Guardant Health on 11 of the 17 factors compared between the two stocks.
Get Addus HomeCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Addus HomeCare Competitors List
Related Companies and Tools
This page (NASDAQ:ADUS) was last updated on 10/19/2025 by MarketBeat.com Staff